ArticleCancers2026

Addition of Venetoclax to Azacitidine Did Not Improve Survival in Acute Myeloid Leukemia and Was Not Well Tolerated: Real World Experience.

David Yanni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.